These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24632222)

  • 1. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study.
    Rienstra M; Vermond RA; Crijns HJ; Tijssen JG; Van Gelder IC;
    Heart Rhythm; 2014 Jun; 11(6):939-45. PubMed ID: 24632222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
    Groenveld HF; Crijns HJ; Rienstra M; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC;
    Am Heart J; 2009 Nov; 158(5):785-91. PubMed ID: 19853699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
    Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Sinagra G; Petrescu L; Tavazzi L; Maggioni AP; Lip GY
    Am J Med; 2015 May; 128(5):509-18.e2. PubMed ID: 25534423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Nakamura M
    Int Heart J; 2010 Mar; 51(2):98-104. PubMed ID: 20379042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
    Disertori M; Lombardi F; Barlera S; Maggioni AP; Favero C; Franzosi MG; Lucci D; Staszewsky L; Fabbri G; Quintarelli S; Bianconi L; Latini R
    Am Heart J; 2011 Aug; 162(2):382-9. PubMed ID: 21835301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study.
    Vermond RA; Crijns HJ; Tijssen JG; Alings AM; Van den Berg MP; Hillege HL; Van Veldhuisen DJ; Van Gelder IC; Rienstra M;
    Europace; 2014 Oct; 16(10):1417-25. PubMed ID: 24938627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
    Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
    Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
    Rienstra M; Hagens VE; Van Veldhuisen DJ; Bosker HA; Tijssen JG; Kamp O; Bouma J; Veeger NJ; Crijns HJ; Van Gelder IC;
    Am J Cardiol; 2004 Dec; 94(12):1486-90. PubMed ID: 15589001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.